Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — Q3 2025 Earnings Presentation
38 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Nov 3, 2025
Slide 1: Q3 2025 Investor Presentation
Q3 2025 Investor Presentation As of 03 November 2025
Slide 2: Presenting Team
Presenting Team Ziyad Al Dahami Faisal Al Nassar Esam Al Mashloum Head of Investor Relations and Treasury Chief Executive Officer Vice President, Finance Q3 2025 HMG Investor Presentation
Slide 3: Agenda
Agenda 1 Financial Performance 2 Projects Update 3 Q&A Key Financial Highlights 5 Projects Update – Completed Projects 11 Q&A 13 Balance Sheet Highlight 7 Projects Update – Future Projects 12 Leverage Levels 8 Declared Cash Dividends 9 Appendices Appendix #1 Appendix #2 Appendix #3 4 Operational Hig
Slide 4: Financial Performance
1 Financial Performance
Slide 5: Key Financial Highlights: Q3 2025
Key Financial Highlights: Q3 2025 Gross profit 5.83% Gross profit Margin % Q3 2025 1,050 Q3 2025 30.32% Q3 2024 992 Q3 2024 33.33% EBITDA 15.14% EBITDA margin % 890 Q3 2025 Q3 2025 25.69% 773 Q3 2024 Q3 2024 25.96% Net income 1.13% Net income margin % Q3 2025 602 17.39% Q3 2025 Q3 2024 596 20.01% Q3
Slide 6: Key Financial Highlights: 9M 2025
Key Financial Highlights: 9M 2025 Gross profit 14.44% Gross profit Margin % 9M 2025 3,144 9M 2025 31.43% 9M 2024 2,747 9M 2024 34.04% EBITDA 19.99% EBITDA margin % 2,564 9M 2025 9M 2025 25.63% 2,137 9M 2024 9M 2024 26.48% Net income 2.87% Net income margin % 9M 2025 1,750 17.49% 9M 2025 9M 2024 1,70
Slide 7: Balance Sheet Highlights
Balance Sheet Highlights million ROE ROA 9M 2024 9M 2025 31.8% 11.1% Total assets Total assets 19,216 22,788 Cash and 33.9% 13.2% bank 2,376 12.36% Cash and Current bank 9.26% Current 20.55% liabilities 2,111 21.12% liabilities ROCE Current Ratio Accounts 3,949 4,813 receivable 6.40% 1,231 Accounts
Slide 8: Leverage Levels
Leverage Levels 120.00% Total liabilities and equity million Liabilities/Total Assets Liabilities/Equity 100.00% 0.64x 1.79x 9M 2025 9M 2025 9M 2024 0.61x 9M 2024 1.59x 80.00% 38.57% 35.89% 7,411 8,179 60.00% Debt / Equity Net Debt / EBITDA 9M 2025 1.12x 9M 2025 2.06x 40.00% 0.99x 9M 2024 1.74x 9M 2
Slide 9: Declared Cash Dividends
Declared Cash Dividends Declared Dividends Pay-out Declared Cash Dividends – Q3 2025 1.21 per share 423.5 mn 70.3% Current Capital 3.5 billion 2025 1.12per 1.19 pershare share 416.5 mn 70.5% 1.12 per share 392.0 mn 70.4% Number of Shares 350 million Dividend to be Distributed 423.50 million 1.23per
Slide 10: Projects Update
2 Projects Update
Slide 11: Projects Update – Completed Projects
Projects Update – Completed Projects Solidifying our market leadership through robust expansion plans and progressing our projects 2024 Al Fayhaa Hospital Women’s Health Al Sahafa Hospital Hospital Ownership Ownership Ownership 50% 100% 100% Jeddah Riyadh Riyadh Opened on Opened on Opened on March 2
Slide 12: Projects Update – Future Projects
Projects Update – Future Projects Solidifying our market leadership through robust expansion plans and progressing our projects Tabuk Hospital Jubail Industrial City Hospital Red Sea Hospital Leased Leased Agreement Agreement Operating and Land Management Land Contract Jubail Tabuk Industrial Red Se
Slide 13: Q&A
3 Q&A OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Slide 14: Operational Highlights
4 Appendix #1 Operational Highlights
Slide 15: Q3 2025 Highlights
Q3 2025 Highlights Accreditations and Awards: - Adaa Health Award Welcomed the 1st batch at Dr. HMG Contract with the Red Sea Real Estate - Extel Awards Sulaiman Al Habib Knowledge Company for the Operation, Management, - The Global Economics Awards College and Maintenance of Red Sea Hospital - The
Slide 16: Medical Excellence
Medical Excellence Creating the medical practitioners of the future and promoting health and well-being Continuous Medical Research Center Postgraduate Program Education 1 Journal issued 90+ Activities 200+ Hours 45+ 14 research paper published Residency & Fellowship program in 40+ Research proposal
Slide 17: ESG and Sustainability
ESG and Sustainability ESG Highlight Major CME Conferences During Q3 2025 • Organized a capacity awareness session with Ertiqa in our Khobar Hospital to promote responsible disposal and reuse of electronic waste. 25th 4th Pediatric Medicine International Nursing • Submitted our annual CDP disclosure
Slide 18: Our People
Our People We continue to attract and retain top talent 60% female Physician Qualifications 29,200+ Workforce 40% male Staff ratio 45% 5,600+ 90%+ Physicians Retention Rate 25% 90+ 36% Nationalities Saudization 30% Training via Virtual Academy Platform Saudi Western (Including North America and UK)
Slide 19: HMG App
HMG App Interaction Booked Appointments +269m +1.67m interactions appointments Habib Live Care Home Healthcare +135.7k +8.7k transactions transactions Q3 2025 HMG Investor Presentation 19
Slide 20: Recognitions
Recognitions Awards Accreditations • Best Corporate in Investor Relations – Pharmaceutical and Healthcare, Large Cap - Council Health Insurance (CHI) Emerging EMEA • Excellence in the Primary • Best Team in Investor Relations – Healthcare Path Pharmaceutical and Healthcare, Large Cap – Emerging EMEA
Slide 21: Investment Case
Investment Case Attractive Industry Fundamentals HMG is committed to patient safety and wellbeing, providing patients with the highest standards of Adaptable Operating Model medical technology, exceptional patient experiences and sustainability to consistently deliver best-in-class care through its
Slide 22: Summarized Financials
5 Appendix #2 Summarized Financials
Slide 23: Financial Review
Financial Review Key Financial Information and KPIs 9M-2025 9M-2024 Statement of Income million Revenue 10,005 8,072 Gross profit 3,144 2,747 Operating income 1,937 1,732 Profit attributable to equity holders of the parent 1,750 1,702 Balance Sheet million Current assets 5,404 4,829 Non-current asse
Slide 24: Financial Review (Continued)
Financial Review (Continued) Key Financial Information and KPIs 9M-2025 9M-2024 Cash Flows million Net cash from operating activities 2,365 1,880 Net cash used in investing activities (2,458) (2,878) Net cash used in financing activities (687) 754 Cash and Cash Equivalents, Beginning of the Period 2
Slide 25: About HMG
6 Appendix #3 About HMG
Slide 26: About HMG
About HMG HMG continues to elevate healthcare delivery and innovation across the Kingdom and the region. Our reputation for providing personalized subsidiaries positions us at the forefront of patient experience supported by cutting- the industry as we continually seek to edge technology across our
Slide 27: Key Message
Key Message Strategic pillars underpin our drive to deliver best-in-class healthcare services Catalysts for value Best-in-class Efficiency drivers creation • Technology: Pioneer in healthcare • Efficient cash conversion cycle: • Regional integrated healthcare technology, award-winning hospital short
Slide 28: Geographic Footprint
Geographic Footprint Sahafa (Riyadh) Fayhaa (Jeddah) Olaya (Riyadh) Muhammadiyah (Jeddah) Rayan (Riyadh) Qassim Takhassusi (Riyadh) Khobar Suwaidi (Riyadh) Sehat Al Kharj (Kharj) Women’s Health (Riyadh) Dubai Hamra (Riyadh) Tabuk Munsiyah (Riyadh) Jubail (Jubail Industrial City) Dammam Ghadeer (Riya
Slide 29: Geographic Footprint (Continued)
Geographic Footprint (Continued) Our Riyadh Presence MAP KEY Hospital Hospital Under Construction Medical Center Medical Center Under Construction Head Office HMG Academy and Knowledge College Urgent Care Q3 2025 HMG Investor Presentation 29
Slide 30: Strategy
Strategy OUR PILLARS Drivers Outcomes Our Growth Strategy Strengthening • Rigorous quality and safety standards • Patient and customer-centric Our forward-thinking corporate strategy creates sustainable value • Top-notch empowered employees value service delivery the Core for our shareholders and st
Slide 31: Business Model
Business Model OUR KEY STRENGTHS WHAT WE DO HMG is uniquely positioned as the leading • Forefront Of Technology and Innovation • Modern Facilities and Comprehensive Services private healthcare group in the region, with the expertise, experience and culture • Trusted Brand in Prime Locations • Sustai
Slide 32: Medical Operation Strategic Pillars
Medical Operation Strategic Pillars Our Fundamental Strategic Pillars Patient Safety Patient Experience Performance and Since its foundation, transformation and evolution, HMG has Enhancing the safety of our Enhancing patient experience by Efficiency always abided by five key strategic pillars that
Slide 33: Pioneer In Healthcare Technology
Pioneer In Healthcare Technology Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) 81 Vida implemented sites Pioneer in healthcare technology, award-winning ▪ Tele-Cardiology (Nabad 24 program): Des
Slide 34: Board of Directors
Board of Directors Non-executives Executives Independents Mr. Faisal Al Nassar Dr. Sulaiman Al Habib Mr. Obaid Al Rasheed Board member, Group CEO and Group Founder and Chairman CFO Vice Chairman Dr. Abdulrahman Mr. Hesham Al Habib Al Turaigi Eng. Saleh Al Habib Board member and Chief Board member Bo
Slide 35: Committee Members
Committee Members Audit Nomination and Remuneration Executive Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Eng. Saleh Al Habib Chairman Chairman Chairman Mr. Turki Al Luhaid Eng. Saleh Al Habib Mr. Faisal Al Nassar Member Member Member Mr. Abdulaziz Al Haidari Mr. Rasheed Al Rasheed Mr. Hesham Al
Slide 36: Executive Management
Executive Management Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Prof. Abdullah Al Herbish Mr. Hesham Al Habib Chief Business Mr. Ahmed Babatin Eng. Abdullah Dr. Riyad Al Atiqi Senior Vice President, Develo
Slide 37: Disclaimer
Disclaimer Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 38: Thank You
Investor Relations Department Thank You King Fahad Road, Olaya District P.O. Box: 91877, Riyadh 11643, Kingdom of Saudi Arabia Phone: + 966 (11) 5259999, Ex. 4919 Fax: + 966 (11) 2174980 Email: investor.relations@drsulaimanalhabib.com OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) — Q3 2025 Earnings Presentation on 6ix